Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system

Thumbnail Image

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

BMC

Abstract

Description

Using a carcinogen-initiated rat model of mammary tumorigenesis, we tested the hypothesis that transforming growth factor (TGF)-βs are useful biomarkers of chemopreventive efficacy in the breast. The chemopreventive agents tested were tamoxifen and the retinoids 9-cis-retinoic acid (9cRA) and N-(4-hydroxyphenyl)retinamide (4-HPR), because both antiestrogens and retinoids have previously been shown to upregulate TGF-βs in vitro. Despite demonstrable chemopreventive efficacy in this model, none of these agents, alone or in combination, had any significant impact on the expression of TGF-βs in the mammary ductal epithelium or periductal stroma as determined by immunohistochemistry. These data suggest that TGF-βs are not likely to be useful biomarkers of chemopreventive efficacy in a clinical setting.

Keywords

Primary Research

Citation

URI

http://salesiana.dossiersoluciones.com/handle/123456789/137

Consulte el texto completo en el siguiente enlace:

https://pmc.ncbi.nlm.nih.gov/articles/PMC13902/
 https://pubmed.ncbi.nlm.nih.gov/11250748/
 https://doi.org/10.1186/bcr273

Collections

PubMed Central